Clinical Trials Logo

Filter by:
NCT ID: NCT02392819 Completed - Clinical trials for Postprandial Blood Glucose Regulation

Effects on Metabolism and Cognitive Functions of a Commonly Used Commercial Food Supplement

Start date: January 2015
Phase: N/A
Study type: Interventional

This project evaluate effects of a commonly used food supplement on glucose metabolism and cognitive function.

NCT ID: NCT02392117 Completed - Clinical trials for Diabetes Mellitus, Type 2

Investigating the Safety and Effectiveness of Insulin Degludec in a Real World Population With Type 1 and 2 Diabetes Mellitus

ReFLeCT
Start date: March 16, 2015
Phase:
Study type: Observational

This study is conducted in Europe. The aim of this non-interventional study is to investigate the safety and effectiveness of insulin degludec (Tresiba®) in a real world population with type 1 (T1DM) and 2 (T2DM) diabetes mellitus.

NCT ID: NCT02389413 Completed - Alzheimer's Disease Clinical Trials

Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease

SAPHIR
Start date: March 2015
Phase: Phase 2
Study type: Interventional

The aim of this study is to evaluate the safety, tolerability and preliminary efficacy of PQ912 in subjects with Mild Cognitive Impairment (MCI) due to Alzheimers Disease (AD) or mild dementia due to AD.

NCT ID: NCT02388906 Active, not recruiting - Melanoma Clinical Trials

Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma

CheckMate 238
Start date: March 19, 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether nivolumab is better than ipilimumab to prevent recurrence of melanoma.

NCT ID: NCT02388295 Completed - Clinical trials for Multiple System Atrophy, MSA

AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients

Start date: April 27, 2015
Phase: Phase 2
Study type: Interventional

AZD3241 myeloperoxidase (MPO) inhibitor trial is assessing safety and tolerability, randomized trial, in patients with Multiple System Atrophy.

NCT ID: NCT02388165 Terminated - Clinical trials for Staphylococcal Vaccine

Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation

STRIVE
Start date: July 2, 2015
Phase: Phase 2
Study type: Interventional

The purposes of the clinical trial are to determine whether the SA4Ag vaccine can prevent postoperative Staphylococcus aureus infections in patients who are undergoing elective spinal fusion surgery, and to evaluate the safety of SA4Ag in patients who are undergoing elective spinal surgery.

NCT ID: NCT02388152 Terminated - Alzheimer Disease Clinical Trials

Study to Evaluate the Safety and Tolerability of a New Drug Named Lu AF20513 in Patients With Mild Alzheimer's Disease

Start date: March 2015
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine if multiple immunizations with Lu AF20513 is tolerable and safe in patients with mild Alzheimer's disease.

NCT ID: NCT02387996 Completed - Clinical trials for Various Advanced Cancer

A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer

Start date: March 9, 2015
Phase: Phase 2
Study type: Interventional

The purpose the study is to measure the effect of nivolumab (BMS-936558) in reducing tumor size in subjects with metastatic or unresectable bladder cancer.

NCT ID: NCT02387164 Terminated - Clinical trials for Diabetes Mellitus, Type 1

Prevention Trial: Immune-tolerance With Alum-GAD (Diamyd) and Vitamin D3 to Children With Multiple Islet Autoantibodies

DiAPREV-IT2
Start date: March 9, 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate if immune-tolerance with Alum-formulated GAD (Diamyd), in combination with high dose Vitamin D3, may delay or stop the autoimmune process leading to clinical type 1 diabetes in non-diabetic children with ongoing beta-cell autoimmunity as indicated by positive islet autoantibodies.

NCT ID: NCT02387034 Recruiting - Osteoarthritis Clinical Trials

Swedish PAP in Osteoarthritis - a RCT Study

Start date: June 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether an intervention with Physical activity on prescription (PAP) to individuals in primary care with knee or hip osteoarthritis would result in effects on physical activity level, physical capacity and quality on life. The hypothesis is that patients with osteoarthritis in hip or knee will increase their level of physical activity significantly more with a PAP intervention compared to patients who only get general advice about physical activity.